Screening for hepatocellular carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 9, 1996, Pages 856-860

  Haydon, Geoffrey H ^a   Hayes, Peter C ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Screening

Indexed keywords

ALPHA FETOPROTEIN; ALPHA LEVO FUCOSIDASE; DECARBOXYPROTHROMBIN; LECTIN;

CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; ECHOGRAPHY; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY;

ALPHA-FETOPROTEINS; ALPHA-L-FUCOSIDASE; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; HUMANS; LIVER NEOPLASMS; MASS SCREENING; NEOPLASM STAGING; PROTEIN PRECURSORS; PROTHROMBIN; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0029781448     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (49)

1. Zhou XD, Tang ZY, Yu YQ: Longterm survivors after resection for primary liver cancer. Clinical analysis of 19 patients surviving more than ten years. Cancer 1988, 63:2201-2206.
2. Haydon GH, Hayes PC: Hepatocellular carcinoma. Br J Hosp Med 1995, 53:74-80.
3. McPeake JR, O'Grady JG, Zaman S, Portmann B, Wight DG, Tan KC, et al.: Liver transplantation for primary hepatocellular carcinoma: tumour size and number determine outcome. J Hepatol 1993, 18:226-234.
4. Suenega M, Nakao A, Harada A, Nonami T Okada Y, Sugiura H, et al.: Hepatic resection for hepatocellular carcinoma. World J Surg 1992, 16:97-104.
5. Okuda K: Hepatocellular carcinoma: recent progress. Hepatology 1992, 5:948-963.
6. Columbo M: Hepatocellular carcinoma in cirrhotics. Semin Liver Dis 1993, 13:374-383.
7. Columbo M: Should patients with chronic viral hepatitis be screened for hepatocellular carcinoma? Viral Hepatitis Reviews 1995, 1:67-75. An excellent review of screening for hepatoelluiar carcinorna, in the context of the present pandemic of chronic hepatitis C infection.
8. Ebara M, Ohto M, Shinagawa I: Natural history of minute hepatocellular carcinoma smaller than three centimeters complicating cirrhosis: a study in 22 patients. Gastroenterology 1986, 90:289-298.
9. Tang ZY: Subclinical hepatocellular carcinoma: historical aspects and general considerations. In Subclinical Hepatoc ellular Carcinoma. Edited by Tang Z. New York: Springer-Verlag; 1985:1 11.
10. McMahon BJ, Lanier AP. Wainwright RB: Hepatocellular carcinoma in Alaska Eskimos: epidemiology, clinical features and early detection. In Progress in Liver Disease, Vol IX. Edited by Popper H, Schaffer F. New York: Harcourt Brace Jovanovich; 1990:643-655.
11. Tang ZY, Yu YQ, Zhou XD: Surgery of small hepatocellular carcinoma. Analysis of 144 cases. Cancer 1989, 64:536 541.
12. Di Bisceglie AM, Hoofnagle JH: Elevations in serum AFP in patients with chronic hepatitis B Cancer 1989, 64:2117-2120.
13. Seef LB, Buskell BZ, Wright FC: Longterm mortality after transfusion associated non-A, non-B hepatitis. N Engl J Med 1992, 327:1906-1911.
14. Resnick R, Koff R: Hepatitis C related hepatocellular carcinoma. Arch Intern Med 1993, 153:1672-1677.
15. Sheu JC, Sung JL, Chen DS: Early detection of hepatocellular carcinoma by real time ultrasonography. A prospective study. Cancer 1985, 56:660 666. First prospective study using ultrasonography for screening of hepatocellular carcinoma.
16. Okuda K: Early recognition of hepatocellular carcinoma. Hepatology 1986, 6:729 738.
17. Oka H, Kurioka N, Kim K, Kanno T, Kuroki T, Mizoguchi Y, et al.: Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis. Hepatology 1990, 12:680 687.
18. Columbo M, de Franchis R, Del Ninno F: Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991, 325:675-680.
19. Taketa K: α-Fetoprotein: reevaluation in hepatology. Hepatology 1990, 12:1420 1429.
20. Maringhini A, Cottone M, Sciarrino E: Ultrasonography and AFP in diagnosis of hepatocellular carcinoma in cirrhotics. Dig Dis Sci 1988, 33:47-51.
21. Kingston M, Ali MA, Lewell D: Hepatic tumours in Saudi Arabia: a practical approach to diagnosis. Cancer, 55:1579-1585.
22. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S: Prospective study of AFP in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994, 19:61-66. First, large, prospective study of AFP screening in cirrhotics; this established sensitivity and specificity of AFP in diagnosing HCC at a range of different levels.
23. Jones AL, Plevris J, Shearing CH, Bouchier IAD, Hayes PC: Analysis of serial serum AFP levels in patients with cirrhosis. Clin Enzym Commun 1994, 6:237 242.
24. Sato Y, Nakata K, Kato Y, Shima M, Ishii N, Koji T, et al.: Early recognition of hepatocellular carcinoma based on altered profiles of AFP. N Engl J Med 1993, 328:1802-1806. Largest study examining lectin profiles of AFP in the diagnosis of HCC.
25. Aoyagi Y, Suzuki Y, Isemuri M, Nomoto M, Sekine C, Igarashi K, et al.: The fucosylation index of AFP and its usefulness in the early diagnosis of hepatocellular carcinoma. Cancer 1988, 61:769-774.
26. Du M-Q, Hutchinson WL, Johnson PJ, Williams R: Differential AFP lectin binding in hepatocellular carcinoma. Cancer 1991, 67:476-480.
27. Aoyagi Y, Saitoh A, Suzuki Y, Igarashi K, Oguro M, Yokota T, et al.: Fucosylation index of AFP, a possible aid in the early recognition of hepatocellular carcinoma in patients with cirrhosis Hepatology 1993, 17:50-52.
28. Blanchard RA, Furie BC, Kruger S, Waneck G, lorgensen MJ, Furie B: Immunoassays of human prothrombin species which correlated with functional coagulant activities. J Lab Clin Med 1983, 101:242-248.
29. Weitz IC, Liebman HA: Des-γ-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 1993, 18:990-997.
30. Soulier JP, Gozin D, Lefrere JJ: A new method to assay des-γ-carboxyprothrombin. Gastroenterology 1986, 91:1258-1262.
31. Takahashi H, Saibara T, Iwamura S, Tomita A, Maeda T, Onishi S, et al.: Serum α-L-fucosidase activity and tumour size in hepatocellular carcinoma. Hepatology 1994, 19:1414-1417.
32. Leandro G, Zizzari S, Piccoli A, Manghisi OG: The serum tissue polypeptide antigen in the detection of hepatocellular carcinoma in cirrhotic patients, Hepatogastroenterology 1990, 37:449-451.
33. Mross KB, Wolfrum DI, Raushecker H: Determination of tissue polypeptide antigen (TPA) levels in different cancer types and controls. Oncology 1985, 42:288-295.
34. Imai H, Nakano Y, Kiyosawa K, Tan EM: Increasing titres and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Cancer 1993, 71:26-35.
35. Shinagawa T, Ohto M, Kiniura K: Diagnosis and clinical features of small hepatocellular carcinoma with emphasis on the utility of real time ultrasonography. A study in 51 patients. Gastroenterology 1984, 86:495-502.
36. Chen DS, Sheu JC, Sung JL: Small hepatocellular carcinoma - a clinicopathological study in thirteen patients. Gastroenterology 1982, 83:1109-1119.
37. McMahon BJ, London T: Workshop on screening for hepatocellular carcinoma. J Natl Cancer Inst 1991, 83:916-919.
38. Ferruci JT: Liver tumour imaging. Cancer 1991, 67:1189 1195.
39. Sun TT, Wan LC, Chang YL: Radiorocket electrophoresis authography (RREA) through labelled antigen for AFP assay and its application for AFP assay and its application in seroepidemiological investigation on primary hepatocellular carcinoma. Chin Med J 1979, 92:17-22.
40. Heyward WL, Lanier AP, McMahon BJ, Fitzgerald MA, Kilkenny S, Paprocki TR: Early detection of hepatocellular carcinoma. Screening for primary hepatocellular carcinoma among patients infected with hepatitis B virus. JAMA 1985, 254:3052-3054.
41. McMahon BJ, Wainwright RW, Lanier AP: The Alaska native HCC screening programme: a population based screening programme for hepatocellular carcinoma. In Aetiology, Pathology, and Treatment of Hepatocellular Carcinoma in North America. Edited by Iabor E, Di Bisceglie AM, Purcell RH. New York: Gulf Publishing Company; 1991:251-242.
42. Pateron D, Ganne N, Trinhet JC, Aurronsean, Mal F, Meicher C, et al.: Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994, 20:65-71.
43. Cotlone M, Turri M, Caltagirone M: Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8 year prospective study by ultrasound and AFP. J Hepatol 1994, 21:1029-1034. A useful study illustrating the improvement in specificity of AFP for the diagnosis of HCC when combined with ultrasound examination.
44. Lightdale CJ: Laparoscopy for cancer staging. Endoscopy 1992, 24:682-686.
45. Tobe T, Arii S: Improving survival after resection of hepatocellular carcinoma: characteristics and current status of surgical treatment of primary liver cancer in Japan. In Primary Liver Cancer in Japan. Edited by Tobe T, Kaneda H, Okudaira M, et al. Tokyo, Berlin, Heidelberg, New York: Springer; 1992.
46. Franco D, Capussoti L, Smadja C, Bonzari M, Meakins J, Kemeny F, et al.: Resection of hepatocellular carcinomas. Results in 72 European patients with cirrhosis, Gastroenterology 1990, 98:713-738.
47. Livraghi T, Bolindi L, Lanzarani S, Marin G, Morabito A, Rapaccini, et al.: Percutaneous injection in the treatment of hepatocellular carcinoma. Study of 207 patients. Cancer 1991, 69:925-929.
48. Ebara M, Otho M, Sujiura N, Kita K, Yoshikawa M, Okuda K, et al.: Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol 1991, 5:616-626.
49. Columbo M: Early diagnosis of hepatocellular carcinoma in Italy. A summary of a Consensus Development Conference held in Milan, 16 November 1990 by the Italian Association for the study of the liver (AISF). J Hepatol 1992, 14:401-403.